The concurrent increase in CCL3 and IL-1β underscores the need to further investigate whether these immune responses confer enhanced parasite control, increased risk of immunopathology, or represent a unique adaptation of chimpanzees to chronic malaria exposure. This evidence concerns the gene IL1B and malaria.